# Coca Cola Co: financial statements, quarterly

KO · NYSE · CIK 21344 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ko.md) · [Financials](/companies/ko/financials.md) · [Filings](/companies/ko/filings.md) · [Insiders](/companies/ko/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ko/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [12.0](/filings/0000021344-24-000044.md) | [12.0](/filings/0000021344-24-000060.md) | [10.8 d](/filings/0001628280-26-010047.md) | [11.3](/filings/0000021344-25-000029.md) | [12.4](/filings/0000021344-25-000061.md) | [11.9](/filings/0001628280-25-046054.md) | [11.5 d](/filings/0001628280-26-010047.md) | [11.1](/filings/0001628280-26-028802.md) | [12.5](/filings/0000021344-25-000061.md) | [12.5](/filings/0001628280-25-046054.md) | [11.8 d](/filings/0001628280-26-010047.md) | [12.5](/filings/0001628280-26-028802.md) |
| Cost of revenue | $bn | [4.9](/filings/0000021344-24-000044.md) | [4.7](/filings/0000021344-24-000060.md) | [4.6 d](/filings/0001628280-26-010047.md) | [4.2](/filings/0000021344-25-000029.md) | [4.8](/filings/0000021344-25-000061.md) | [4.7](/filings/0001628280-25-046054.md) | [4.6 d](/filings/0001628280-26-010047.md) | [4.2](/filings/0001628280-26-028802.md) | [4.7](/filings/0000021344-25-000061.md) | [4.8](/filings/0001628280-25-046054.md) | [4.7 d](/filings/0001628280-26-010047.md) | [4.6](/filings/0001628280-26-028802.md) |
| Gross profit | $bn | [7.1](/filings/0000021344-24-000044.md) | [7.3](/filings/0000021344-24-000060.md) | [6.2 d](/filings/0001628280-26-010047.md) | [7.1](/filings/0000021344-25-000029.md) | [7.6](/filings/0000021344-25-000061.md) | [7.2](/filings/0001628280-25-046054.md) | [6.9 d](/filings/0001628280-26-010047.md) | [7.0](/filings/0001628280-26-028802.md) | [7.8](/filings/0000021344-25-000061.md) | [7.7](/filings/0001628280-25-046054.md) | [7.1 d](/filings/0001628280-26-010047.md) | [7.9](/filings/0001628280-26-028802.md) |
| Selling, general and administrative | $bn | [3.3](/filings/0000021344-24-000044.md) | [3.7](/filings/0000021344-24-000060.md) | [3.8 d](/filings/0001628280-26-010047.md) | [3.4](/filings/0000021344-25-000029.md) | [3.5](/filings/0000021344-25-000061.md) | [3.6](/filings/0001628280-25-046054.md) | [4.0 d](/filings/0001628280-26-010047.md) | [3.2](/filings/0001628280-26-028802.md) | [3.5](/filings/0000021344-25-000061.md) | [3.6](/filings/0001628280-25-046054.md) | [4.2 d](/filings/0001628280-26-010047.md) | [3.5](/filings/0001628280-26-028802.md) |
| Operating income | $bn | [2.4](/filings/0000021344-24-000044.md) | [3.3](/filings/0000021344-24-000060.md) | [2.3 d](/filings/0001628280-26-010047.md) | [2.1](/filings/0000021344-25-000029.md) | [2.6](/filings/0000021344-25-000061.md) | [2.5](/filings/0001628280-25-046054.md) | [2.7 d](/filings/0001628280-26-010047.md) | [3.7](/filings/0001628280-26-028802.md) | [4.3](/filings/0000021344-25-000061.md) | [4.0](/filings/0001628280-25-046054.md) | [1.8 d](/filings/0001628280-26-010047.md) | [4.4](/filings/0001628280-26-028802.md) |
| Interest expense | $bn | [0.4](/filings/0000021344-23-000048.md) | [0.4](/filings/0000021344-23-000060.md) | [0.4 d](/filings/0001628280-26-010047.md) | [0.4](/filings/0000021344-25-000029.md) | [0.4](/filings/0000021344-25-000061.md) | [0.4](/filings/0001628280-25-046054.md) | [0.4 d](/filings/0001628280-26-010047.md) | [0.4](/filings/0001628280-26-028802.md) | [0.4](/filings/0000021344-25-000061.md) | [0.4](/filings/0001628280-25-046054.md) | [0.4 d](/filings/0001628280-26-010047.md) | [0.4](/filings/0001628280-26-028802.md) |
| Income tax | $bn | [0.4](/filings/0000021344-24-000044.md) | [0.5](/filings/0000021344-24-000060.md) | [0.5 d](/filings/0001628280-26-010047.md) | [0.7](/filings/0000021344-25-000029.md) | [0.6](/filings/0000021344-25-000061.md) | [0.5](/filings/0001628280-25-046054.md) | [0.6 d](/filings/0001628280-26-010047.md) | [0.7](/filings/0001628280-26-028802.md) | [1.0](/filings/0000021344-25-000061.md) | [0.5](/filings/0001628280-25-046054.md) | [0.6 d](/filings/0001628280-26-010047.md) | [0.6](/filings/0001628280-26-028802.md) |
| Net income | $bn | [2.5](/filings/0000021344-24-000044.md) | [3.1](/filings/0000021344-24-000060.md) | [2.0 d](/filings/0001628280-26-010047.md) | [3.2](/filings/0000021344-25-000029.md) | [2.4](/filings/0000021344-25-000061.md) | [2.8](/filings/0001628280-25-046054.md) | [2.2 d](/filings/0001628280-26-010047.md) | [3.3](/filings/0001628280-26-028802.md) | [3.8](/filings/0000021344-25-000061.md) | [3.7](/filings/0001628280-25-046054.md) | [2.3 d](/filings/0001628280-26-010047.md) | [3.9](/filings/0001628280-26-028802.md) |
| Diluted EPS | $ per share | [0.59](/filings/0000021344-24-000044.md) | [0.71](/filings/0000021344-24-000060.md) | not reported | [0.74](/filings/0000021344-25-000029.md) | [0.56](/filings/0000021344-25-000061.md) | [0.66](/filings/0001628280-25-046054.md) | not reported | [0.77](/filings/0001628280-26-028802.md) | [0.88](/filings/0000021344-25-000061.md) | [0.86](/filings/0001628280-25-046054.md) | not reported | [0.91](/filings/0001628280-26-028802.md) |
| Basic EPS | $ per share | [0.59](/filings/0000021344-24-000044.md) | [0.71](/filings/0000021344-24-000060.md) | not reported | [0.74](/filings/0000021344-25-000029.md) | [0.56](/filings/0000021344-25-000061.md) | [0.66](/filings/0001628280-25-046054.md) | not reported | [0.77](/filings/0001628280-26-028802.md) | [0.89](/filings/0000021344-25-000061.md) | [0.86](/filings/0001628280-25-046054.md) | not reported | [0.91](/filings/0001628280-26-028802.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [12.6](/filings/0000021344-24-000044.md) | [11.9](/filings/0000021344-24-000060.md) | [9.4](/filings/0001628280-26-010047.md) | [10.4](/filings/0000021344-25-000029.md) | [13.7](/filings/0000021344-25-000061.md) | [13.9](/filings/0001628280-25-046054.md) | [10.8](/filings/0001628280-26-028802.md) | [8.4](/filings/0001628280-26-028802.md) | [9.6](/filings/0000021344-25-000061.md) | [12.7](/filings/0001628280-25-046054.md) | [10.3](/filings/0001628280-26-028802.md) | [10.6](/filings/0001628280-26-028802.md) |
| Current assets | $bn | [27.6](/filings/0000021344-23-000048.md) | [27.9](/filings/0000021344-23-000060.md) | [26.7](/filings/0000021344-25-000011.md) | [29.5](/filings/0000021344-24-000017.md) | [31.6](/filings/0000021344-24-000044.md) | [30.3](/filings/0000021344-24-000060.md) | [26.0](/filings/0001628280-26-010047.md) | [26.2](/filings/0000021344-25-000029.md) | [26.6](/filings/0000021344-25-000061.md) | [27.2](/filings/0001628280-25-046054.md) | [31.0](/filings/0001628280-26-028802.md) | [30.4](/filings/0001628280-26-028802.md) |
| Total assets | $bn | [98.5](/filings/0000021344-23-000048.md) | [97.6](/filings/0000021344-23-000060.md) | [97.7](/filings/0000021344-25-000011.md) | [99.4](/filings/0000021344-24-000017.md) | [101](/filings/0000021344-24-000044.md) | [106](/filings/0000021344-24-000060.md) | [101](/filings/0001628280-26-010047.md) | [102](/filings/0000021344-25-000029.md) | [104](/filings/0000021344-25-000061.md) | [106](/filings/0001628280-25-046054.md) | [105](/filings/0001628280-26-028802.md) | [104](/filings/0001628280-26-028802.md) |
| Current liabilities | $bn | [24.1](/filings/0000021344-23-000048.md) | [24.4](/filings/0000021344-23-000060.md) | [23.6](/filings/0000021344-25-000011.md) | [28.4](/filings/0000021344-24-000017.md) | [29.3](/filings/0000021344-24-000044.md) | [28.6](/filings/0000021344-24-000060.md) | [25.2](/filings/0001628280-26-010047.md) | [23.8](/filings/0000021344-25-000029.md) | [21.9](/filings/0000021344-25-000061.md) | [22.5](/filings/0001628280-25-046054.md) | [21.3](/filings/0001628280-26-028802.md) | [22.4](/filings/0001628280-26-028802.md) |
| Long-term debt | $bn | [35.6](/filings/0000021344-23-000048.md) | [34.2](/filings/0000021344-23-000060.md) | [35.5](/filings/0000021344-24-000017.md) | [35.1](/filings/0000021344-24-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [1.2](/filings/0000021344-23-000048.md) | [2.1](/filings/0000021344-23-000060.md) | [2.0](/filings/0000021344-24-000017.md) | [1.4](/filings/0000021344-24-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [4.6](/filings/0000021344-23-000048.md) | [3.7](/filings/0000021344-23-000060.md) | [4.2](/filings/0000021344-25-000011.md) | [5.7](/filings/0000021344-24-000017.md) | [3.5](/filings/0000021344-24-000044.md) | [1.8](/filings/0000021344-24-000060.md) | [1.1](/filings/0001628280-26-010047.md) | [5.0](/filings/0000021344-25-000029.md) | [4.0](/filings/0000021344-25-000061.md) | [2.0](/filings/0001628280-25-046054.md) | [1.5](/filings/0001628280-26-028802.md) | [0.3](/filings/0001628280-26-028802.md) |
| Shareholders' equity | $bn | [26.0](/filings/0000021344-23-000048.md) | [26.3](/filings/0000021344-23-000060.md) | [25.9](/filings/0000021344-25-000011.md) | [26.4](/filings/0000021344-24-000017.md) | [25.9](/filings/0000021344-24-000044.md) | [26.5](/filings/0000021344-24-000060.md) | [24.9](/filings/0001628280-26-010047.md) | [26.2](/filings/0000021344-25-000029.md) | [28.6](/filings/0000021344-25-000061.md) | [31.2](/filings/0001628280-25-046054.md) | [32.2](/filings/0001628280-26-028802.md) | [33.6](/filings/0001628280-26-028802.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,469 d](/filings/0000021344-24-000044.md) | [4,300 d](/filings/0000021344-24-000060.md) | [2,670 d](/filings/0001628280-26-010047.md) | [528](/filings/0000021344-25-000029.md) | [3,585 d](/filings/0000021344-25-000061.md) | [(1,259) d](/filings/0001628280-25-046054.md) | [3,951 d](/filings/0001628280-26-010047.md) | [(5,202)](/filings/0001628280-26-028802.md) | [3,811 d](/filings/0000021344-25-000061.md) | [5,043 d](/filings/0001628280-25-046054.md) | [3,756 d](/filings/0001628280-26-010047.md) | [2,021](/filings/0001628280-26-028802.md) |
| Capital expenditure | $m | [339 d](/filings/0000021344-24-000044.md) | [386 d](/filings/0000021344-24-000060.md) | [851 d](/filings/0001628280-26-010047.md) | [370](/filings/0000021344-25-000029.md) | [422 d](/filings/0000021344-25-000061.md) | [469 d](/filings/0001628280-25-046054.md) | [803 d](/filings/0001628280-26-010047.md) | [309](/filings/0001628280-26-028802.md) | [442 d](/filings/0000021344-25-000061.md) | [479 d](/filings/0001628280-25-046054.md) | [882 d](/filings/0001628280-26-010047.md) | [266](/filings/0001628280-26-028802.md) |
| Dividends paid | $m | [1,988 d](/filings/0000021344-24-000044.md) | [1,989 d](/filings/0000021344-24-000060.md) | [3,874 d](/filings/0001628280-26-010047.md) | [99.0](/filings/0000021344-25-000029.md) | [2,085 d](/filings/0000021344-25-000061.md) | [2,090 d](/filings/0001628280-25-046054.md) | [4,085 d](/filings/0001628280-26-010047.md) | [89.0](/filings/0001628280-26-028802.md) | [2,194 d](/filings/0000021344-25-000061.md) | [2,108 d](/filings/0001628280-25-046054.md) | [4,388 d](/filings/0001628280-26-010047.md) | [2,281](/filings/0001628280-26-028802.md) |
| Share repurchases | $m | [236 d](/filings/0000021344-24-000044.md) | [109 d](/filings/0000021344-24-000060.md) | [1,096 d](/filings/0001628280-26-010047.md) | [702](/filings/0000021344-25-000029.md) | [172 d](/filings/0000021344-25-000061.md) | [354 d](/filings/0001628280-25-046054.md) | [567 d](/filings/0001628280-26-010047.md) | [370](/filings/0001628280-26-028802.md) | [102 d](/filings/0000021344-25-000061.md) | [172 d](/filings/0001628280-25-046054.md) | [102 d](/filings/0001628280-26-010047.md) | [477](/filings/0001628280-26-028802.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-07-01) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-29) | Q1 FY2024 (2024-03-29) | Q2 FY2024 (2024-06-28) | Q3 FY2024 (2024-09-27) | Q1 FY2025 (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q1 FY2026 (2026-04-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4,353](/filings/0000021344-23-000048.md) | [4,346](/filings/0000021344-23-000060.md) | [4,345](/filings/0000021344-24-000017.md) | [4,341](/filings/0000021344-24-000044.md) | [4,339](/filings/0000021344-24-000060.md) | [4,322](/filings/0000021344-25-000029.md) | [4,319](/filings/0000021344-25-000061.md) | [4,323](/filings/0001628280-25-046054.md) | [4,313](/filings/0001628280-26-028802.md) | [4,315](/filings/0000021344-25-000061.md) | [4,313](/filings/0001628280-25-046054.md) | [4,314](/filings/0001628280-26-028802.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,302,482,418 at 2026-04-28, from the cover of the [10-Q filed 2026-04-30](/filings/0001628280-26-028802.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.